The ESMO TAT Asia Congress 2025 is placed to become a catalyst for global collaboration and innovation in oncology, recognising the region’s growing leadership in early drug development and creating new opportunities for cross-border partnerships.
The ESMO TAT Asia Congress 2025 is placed to become a catalyst for global collaboration and innovation in oncology, recognising the region’s growing leadership in early drug development and creating new opportunities for cross-border partnerships.
